Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1260.496 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1260.496/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.496 |
Version | 20240921 |
Status | active |
Date | 2024-09-21T01:08:32-04:00 |
Name | Pembrolizumab |
Title | Pembrolizumab |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: ) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113762.1.4.1260.496", "meta": { "versionId": "5", "lastUpdated": "2024-09-21T01:08:32.000-04:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "CancerLinQ Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2024-09-21" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2024-09-21" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.496", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113762.1.4.1260.496" } ], "version": "20240921", "name": "Pembrolizumab", "title": "Pembrolizumab", "status": "active", "date": "2024-09-21T01:08:32-04:00", "publisher": "CancerLinQ Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "1547545", "display": "pembrolizumab" }, { "code": "1547546", "display": "pembrolizumab 25 MG/ML" }, { "code": "1547547", "display": "pembrolizumab Injectable Product" }, { "code": "1547550", "display": "Keytruda" }, { "code": "1547551", "display": "pembrolizumab 25 MG/ML [Keytruda]" }, { "code": "1547553", "display": "Keytruda Injectable Product" }, { "code": "1657744", "display": "pembrolizumab 50 MG" }, { "code": "1657745", "display": "pembrolizumab Injection" }, { "code": "1657746", "display": "pembrolizumab 50 MG Injection" }, { "code": "1657747", "display": "pembrolizumab 50 MG [Keytruda]" }, { "code": "1657748", "display": "pembrolizumab Injection [Keytruda]" }, { "code": "1657749", "display": "pembrolizumab 50 MG Injection [Keytruda]" }, { "code": "1657750", "display": "4 ML pembrolizumab 25 MG/ML Injection" }, { "code": "1657751", "display": "4 ML pembrolizumab 25 MG/ML Injection [Keytruda]" } ] } ] }, "expansion": { "identifier": "urn:uuid:c362aef5-cbc4-4438-a47d-7b25b5f7228f", "timestamp": "2025-05-23T21:18:27-04:00", "total": 12, "contains": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1547545", "display": "pembrolizumab" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1547546", "display": "pembrolizumab 25 MG/ML" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1547547", "display": "pembrolizumab Injectable Product" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1547550", "display": "Keytruda" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1547551", "display": "pembrolizumab 25 MG/ML [Keytruda]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1547553", "display": "Keytruda Injectable Product" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1657744", "display": "pembrolizumab 50 MG" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1657745", "display": "pembrolizumab Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1657746", "display": "pembrolizumab 50 MG Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1657748", "display": "pembrolizumab Injection [Keytruda]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1657750", "display": "4 ML pembrolizumab 25 MG/ML Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1657751", "display": "4 ML pembrolizumab 25 MG/ML Injection [Keytruda]" } ] } }